Raymond James & Associates »

Crinetics Pharmaceuticals In shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $310k 6.6k 46.81